99mTc-3PRGD2 SPECT/CT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 99mTc-3PRGD2 SPECT/CT, covering 2017-04-07 to 2017-04-07. Get the full timeline:
Most recent: Clinical Trial Update: 99mTc-3PRGD2 SPECT/CT in Lung Cancer Patients [EARLY_Phase 1]